And those opportunities are growing, as 8% to 10% of Americans now take a GLP-1 and 30% to 35% have indicated interest in taking one, according to PricewaterhouseCoopers
Surface receptor loss was calculated from 620 nm over 520 nm signals
Association of metabolic obesity phenotypes with risk of overall and site-specific cancers: a systematic review and meta-analysis of cohort studies
GLP-1 acts through its receptors, GLP-1R, which is expressed in different tissues, including the pancreas, heart, kidney, adipose, and central nervous system
Those systems developed together
Interestingly, the shortage has not affected product doses equally, with some doses more available than others